ACG Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.11M | Buy |
8,284
+378
| +5% | +$54.2K | 0.25% | 102 |
|
|
2022
Q2 | $1.21M | Buy |
7,906
+712
| +10% | +$109K | 0.25% | 99 |
|
|
2022
Q1 | $1.17M | Sell |
7,194
-5,901
| -45% | -$857K | 0.22% | 114 |
|
|
2021
Q4 | $1.77M | Sell |
13,095
-1,963
| -13% | -$232K | 0.25% | 94 |
|
|
2021
Q3 | $1.62M | Sell |
15,058
-447
| -3% | -$51.1K | 0.21% | 100 |
|
|
2021
Q2 | $1.75M | Sell |
15,505
-856
| -5% | -$96.4K | 0.22% | 91 |
|
|
2021
Q1 | $1.77M | Buy |
16,361
+191
| +1% | +$20.4K | 0.23% | 91 |
|
|
2020
Q4 | $1.73M | Sell |
16,170
-327
| -2% | -$31.4K | 0.24% | 87 |
|
|
2020
Q3 | $1.45M | Buy |
16,497
+618
| +4% | +$58.2K | 0.22% | 90 |
|
|
2020
Q2 | $1.56M | Sell |
15,879
-7,002
| -31% | -$616K | 0.25% | 79 |
|
|
2020
Q1 | $1.74M | Sell |
22,881
-2,420
| -10% | -$206K | 0.32% | 75 |
|
|
2019
Q4 | $2.24M | Sell |
25,301
-283
| -1% | -$23.5K | 0.33% | 75 |
|
|
2019
Q3 | $1.94M | Buy |
25,584
+33
| +0.1% | +$2.26K | 0.29% | 75 |
|
|
2019
Q2 | $1.86M | Sell |
25,551
-4,684
| -15% | -$368K | 0.25% | 89 |
|
|
2019
Q1 | $2.44M | Sell |
30,235
-6,649
| -18% | -$544K | 0.33% | 73 |
|
|
2018
Q4 | $3.4M | Buy |
36,884
+643
| +2% | +$56.5K | 0.52% | 49 |
|
|
2018
Q3 | $3.43M | Sell |
36,241
-1,563
| -4% | -$148K | 0.45% | 57 |
|
|
2018
Q2 | $3.5M | Buy |
37,804
+1,842
| +5% | +$180K | 0.53% | 48 |
|
|
2018
Q1 | $3.4M | Buy |
35,962
+2,333
| +7% | +$256K | 0.52% | 53 |
|
|
2017
Q4 | $3.25M | Buy |
33,629
+5,272
| +19% | +$497K | 0.48% | 56 |
|
|
2017
Q3 | $2.52M | Sell |
28,357
-6,869
| -19% | -$523K | 0.44% | 61 |
|
|
2017
Q2 | $2.55M | Sell |
35,226
-2,677
| -7% | -$180K | 0.42% | 64 |
|
|
2017
Q1 | $2.47M | Buy |
37,903
+5,630
| +17% | +$354K | 0.45% | 66 |
|
|
2016
Q4 | $2.02M | Sell |
32,273
-11,004
| -25% | -$672K | 0.43% | 69 |
|
|
2016
Q3 | $2.73M | Sell |
43,277
-1,364
| -3% | -$88.3K | 0.58% | 48 |
|
|
2016
Q2 | $2.76M | Buy |
44,641
+706
| +2% | +$43K | 0.62% | 45 |
|
|
2016
Q1 | $2.51M | Buy |
43,935
+10,855
| +33% | +$605K | 0.57% | 52 |
|
|
2015
Q4 | $1.96M | Buy |
33,080
+23,211
| +235% | +$1.34M | 0.44% | 70 |
|
|
2015
Q3 | $537K | Sell |
9,869
-969
| -9% | -$63.1K | 0.14% | 116 |
|
|
2015
Q2 | $729K | Buy |
10,838
+2,214
| +26% | +$145K | 0.18% | 105 |
|
|
2015
Q1 | $505K | Buy |
8,624
+560
| +7% | +$33.8K | 0.13% | 125 |
|
|
2014
Q4 | $528K | Buy |
8,064
+225
| +3% | +$14.2K | 0.14% | 123 |
|
|
2014
Q3 | $453K | Sell |
7,839
-4,223
| -35% | -$234K | 0.13% | 129 |
|
|
2014
Q2 | $681K | Buy |
12,062
+4,515
| +60% | +$237K | 0.13% | 114 |
|
|
2014
Q1 | $388K | Sell |
7,547
-3,004
| -28% | -$152K | 0.12% | 134 |
|
|
2013
Q4 | $557K | Buy |
+10,551
| New | +$519K | 0.14% | 106 |
|
|
2013
Q3 | – | Sell |
-11,211
| Closed | -$463K | – | 89 |
|
|
2013
Q2 | $463K | Buy |
+11,211
| New | +$490K | 0.18% | 92 |
|
Other funds holding ABBV
ACG Wealth's ABBV Position: Q3 2022 in Review
ACG Wealth increased its AbbVie (ABBV) stake by 4.8% in Q3 2022, buying an estimated $54.2K and bringing the position to 8,284 shares worth $1.11M. The position accounts for 0.25% of the portfolio, ranked #102.
ACG Wealth first reported a position in ABBV in Q2 2013 and has held it in 37 quarters since. The position peaked at $3.5M in Q2 2018. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- ACG Wealth held 8,284 shares of AbbVie worth $1.11M as of Q3 2022.
- ACG Wealth bought 378 AbbVie shares in Q3 2022, an estimated $54.2K.
- AbbVie made up 0.25% of ACG Wealth's portfolio in Q3 2022, its #102 holding.
- ACG Wealth first reported a position in AbbVie in Q2 2013 and has held it in 37 quarters since.
- ACG Wealth's AbbVie position peaked at $3.5M in Q2 2018.
- 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.